These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27409729)

  • 21. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
    Seitz S; Buchholz S; Schally AV; Jayakumar AR; Weber F; Papadia A; Rick FG; Szalontay L; Treszl A; Köster F; Ortmann O; Hohla F
    Anticancer Drugs; 2013 Feb; 24(2):150-7. PubMed ID: 23080077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.
    Arne G; Nilsson B; Dalmo J; Kristiansson E; Arvidsson Y; Forssell-Aronsson E; Nilsson O; Ahlman H
    Acta Oncol; 2013 May; 52(4):783-92. PubMed ID: 23116418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
    Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin, its receptors and analogs, in lung cancer.
    O'Byrne KJ; Schally AV; Thomas A; Carney DN; Steward WP
    Chemotherapy; 2001; 47 Suppl 2():78-108. PubMed ID: 11275704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabelled regulatory peptides for imaging and therapy.
    Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
    Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies.
    Woelfl S; Bogner S; Huber H; Salaheddin-Nassr S; Hatzl M; Decristoforo C; Virgolini I; Gabriel M
    Nuklearmedizin; 2014; 53(5):179-85. PubMed ID: 24967740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
    Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The present and future role of (111)In pentetreotide in the PET era.
    Rambaldi PF; Cuccurullo V; Briganti V; Mansi L
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):225-35. PubMed ID: 16172568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of breast cancer: is there a role for somatostatin and its analogs?
    Boccardo F; Amoroso D
    Chemotherapy; 2001; 47 Suppl 2():62-77. PubMed ID: 11275703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
    Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
    Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New trends in peptide receptor radioligands.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Andreae F; Kurtaran A; Dudczak R
    Q J Nucl Med; 2001 Jun; 45(2):153-9. PubMed ID: 11476164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine neoplasms and somatostatin receptor subtypes expression.
    Hankus J; Tomaszewska R
    Nucl Med Rev Cent East Eur; 2016; 19(2):111-7. PubMed ID: 27479788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field.
    Dalm VA; Hofland LJ; Lamberts SW
    Mol Cell Endocrinol; 2008 May; 286(1-2):262-77. PubMed ID: 17942217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SSTR1 and SSTR5 subtypes are the dominant forms of somatostatin receptor in neuroendocrine tumors.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Kubiak R; Winczyk K
    Folia Histochem Cytobiol; 2010 Jan; 48(1):142-7. PubMed ID: 20529830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
    Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
    Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.